RDY Gross Profit from 2010 to 2024

RDY Stock

USD 14.14 0.06 0.43%

Dr Reddys Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Dr Reddys Laboratories makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2001-03-31

Previous Quarter

46.3 B

Current Value

47.8 B

Quarterly Volatility

12.3 B

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 1.8 B, Total Revenue of 293.1 B or Gross Profit of 171.8 B, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0061 or PTB Ratio of 3.89. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.

Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Dr Reddys Laboratories over the last few years. Gross profit is a required income statement account that reflects total revenue of Dr Reddys Laboratories minus its cost of goods sold. It is profit before Dr Reddys operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Dr Reddys' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 113.84 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

RDY Gross Profit Regression Statistics

	Arithmetic Mean	96,984,845,400
	Geometric Mean	55,048,300,267
	Coefficient Of Variation	52.14
	Mean Deviation	36,047,883,067
	Median	85,403,000,000
	Standard Deviation	50,565,369,748
	Sample Variance	2556856617.7T
	Range	203B
	R-Value	0.88
	Mean Square Error	615283218.7T
	R-Squared	0.78
	Significance	0.000014
	Slope	9,963,739,761
	Total Sum of Squares	35795992648.1T

RDY Gross Profit History

	2024	171.8 B
	2023	163.6 B
	2022	203 B
	2021	113.8 B
	2020	103.1 B
	2019	94 B
	2018	83.4 B

Other Fundumenentals of Dr Reddys Laboratories

Gross Profit Margin

Dr Reddys Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Net Receivables	Good Will	Total Current Assets	Treasury Stock	Short Term Debt	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	-0.06	0.99	-0.14	0.91	0.99	0.91	0.98	-0.16	-0.05	0.96	1.0	0.98	1.0	0.03	0.96	0.04	-0.08	0.19	-0.14	-0.18	0.11	0.03	0.02	-0.07
Total Stockholder Equity	0.96		0.19	0.94	-0.15	0.97	0.93	0.87	0.91	0.04	0.07	0.88	0.95	0.95	0.96	-0.16	0.89	0.16	0.03	0.07	-0.18	-0.11	0.14	0.23	0.21	0.18
Retained Earnings	-0.06	0.19		-0.15	0.09	0.21	-0.18	0.04	-0.22	0.87	0.7	-0.27	-0.08	-0.12	-0.04	-0.84	-0.26	0.68	0.65	-0.54	0.02	0.38	-0.1	0.83	0.85	0.56
Accounts Payable	0.99	0.94	-0.15		-0.13	0.89	1.0	0.9	0.99	-0.24	-0.16	0.98	0.99	0.99	0.99	0.13	0.98	-0.05	-0.16	0.26	-0.13	-0.22	0.15	-0.05	-0.07	-0.06
Long Term Debt	-0.14	-0.15	0.09	-0.13		-0.24	-0.13	0.19	-0.16	0.4	0.07	-0.06	-0.18	-0.15	-0.18	0.11	-0.16	0.0	0.21	-0.22	0.99	0.44	-0.49	-0.15	-0.14	-0.08
Short Term Investments	0.91	0.97	0.21	0.89	-0.24		0.88	0.77	0.87	-0.01	-0.01	0.81	0.91	0.91	0.92	-0.13	0.83	0.12	-0.1	-0.01	-0.28	-0.14	0.32	0.3	0.27	0.25
Total Liab	0.99	0.93	-0.18	1.0	-0.13	0.88		0.89	1.0	-0.26	-0.16	0.98	0.99	0.99	0.98	0.16	0.99	-0.09	-0.17	0.27	-0.14	-0.23	0.13	-0.09	-0.12	-0.06
Intangible Assets	0.91	0.87	0.04	0.9	0.19	0.77	0.89		0.86	0.08	0.03	0.9	0.89	0.88	0.88	0.02	0.87	0.07	0.14	0.17	0.18	-0.02	-0.09	0.0	0.0	-0.08
Common Stock	0.98	0.91	-0.22	0.99	-0.16	0.87	1.0	0.86		-0.31	-0.21	0.98	0.98	0.99	0.97	0.19	0.99	-0.14	-0.23	0.29	-0.17	-0.25	0.16	-0.14	-0.16	-0.04
Property Plant Equipment	-0.16	0.04	0.87	-0.24	0.4	-0.01	-0.26	0.08	-0.31		0.66	-0.31	-0.19	-0.22	-0.17	-0.7	-0.33	0.7	0.74	-0.48	0.36	0.68	-0.3	0.61	0.64	0.38
Current Deferred Revenue	-0.05	0.07	0.7	-0.16	0.07	-0.01	-0.16	0.03	-0.21	0.66		-0.22	-0.07	-0.13	-0.04	-0.86	-0.23	0.65	0.75	-0.42	0.08	0.34	-0.6	0.51	0.58	0.11
Net Debt	0.96	0.88	-0.27	0.98	-0.06	0.81	0.98	0.9	0.98	-0.31	-0.22		0.96	0.97	0.94	0.24	0.98	-0.15	-0.18	0.37	-0.06	-0.29	0.07	-0.19	-0.2	-0.1
Net Receivables	1.0	0.95	-0.08	0.99	-0.18	0.91	0.99	0.89	0.98	-0.19	-0.07	0.96		0.99	1.0	0.06	0.97	0.01	-0.13	0.19	-0.18	-0.19	0.13	0.0	0.0	-0.07
Good Will	0.98	0.95	-0.12	0.99	-0.15	0.91	0.99	0.88	0.99	-0.22	-0.13	0.97	0.99		0.98	0.1	0.98	-0.07	-0.15	0.24	-0.16	-0.21	0.14	-0.06	-0.08	0.02
Total Current Assets	1.0	0.96	-0.04	0.99	-0.18	0.92	0.98	0.88	0.97	-0.17	-0.04	0.94	1.0	0.98		0.01	0.95	0.06	-0.1	0.18	-0.19	-0.19	0.13	0.07	0.06	-0.06
Treasury Stock	0.03	-0.16	-0.84	0.13	0.11	-0.13	0.16	0.02	0.19	-0.7	-0.86	0.24	0.06	0.1	0.01		0.24	-0.82	-0.75	0.34	0.15	-0.25	0.3	-0.8	-0.83	-0.35
Short Term Debt	0.96	0.89	-0.26	0.98	-0.16	0.83	0.99	0.87	0.99	-0.33	-0.23	0.98	0.97	0.98	0.95	0.24		-0.19	-0.21	0.33	-0.16	-0.25	0.15	-0.19	-0.22	-0.06
Net Tangible Assets	0.04	0.16	0.68	-0.05	0.0	0.12	-0.09	0.07	-0.14	0.7	0.65	-0.15	0.01	-0.07	0.06	-0.82	-0.19		0.65	-0.16	-0.03	0.42	-0.26	0.75	0.8	0.06
Long Term Investments	-0.08	0.03	0.65	-0.16	0.21	-0.1	-0.17	0.14	-0.23	0.74	0.75	-0.18	-0.13	-0.15	-0.1	-0.75	-0.21	0.65		-0.04	0.19	0.27	-0.43	0.52	0.53	0.14
Short Long Term Debt	0.19	0.07	-0.54	0.26	-0.22	-0.01	0.27	0.17	0.29	-0.48	-0.42	0.37	0.19	0.24	0.18	0.34	0.33	-0.16	-0.04		-0.22	-0.57	0.08	-0.34	-0.38	-0.17
Long Term Debt Total	-0.14	-0.18	0.02	-0.13	0.99	-0.28	-0.14	0.18	-0.17	0.36	0.08	-0.06	-0.18	-0.16	-0.19	0.15	-0.16	-0.03	0.19	-0.22		0.46	-0.52	-0.23	-0.2	-0.16
Capital Surpluse	-0.18	-0.11	0.38	-0.22	0.44	-0.14	-0.23	-0.02	-0.25	0.68	0.34	-0.29	-0.19	-0.21	-0.19	-0.25	-0.25	0.42	0.27	-0.57	0.46		-0.27	0.12	0.14	0.05
Cash And Equivalents	0.11	0.14	-0.1	0.15	-0.49	0.32	0.13	-0.09	0.16	-0.3	-0.6	0.07	0.13	0.14	0.13	0.3	0.15	-0.26	-0.43	0.08	-0.52	-0.27		0.16	0.08	0.22
Net Invested Capital	0.03	0.23	0.83	-0.05	-0.15	0.3	-0.09	0.0	-0.14	0.61	0.51	-0.19	0.0	-0.06	0.07	-0.8	-0.19	0.75	0.52	-0.34	-0.23	0.12	0.16		0.98	0.34
Net Working Capital	0.02	0.21	0.85	-0.07	-0.14	0.27	-0.12	0.0	-0.16	0.64	0.58	-0.2	0.0	-0.08	0.06	-0.83	-0.22	0.8	0.53	-0.38	-0.2	0.14	0.08	0.98		0.27
Capital Stock	-0.07	0.18	0.56	-0.06	-0.08	0.25	-0.06	-0.08	-0.04	0.38	0.11	-0.1	-0.07	0.02	-0.06	-0.35	-0.06	0.06	0.14	-0.17	-0.16	0.05	0.22	0.34	0.27

Click cells to compare fundamentals

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	163.6 B	171.8 B
Gross Profit Margin	0.59	0.43

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC